Asenapine: all 42 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.CompletedNCT02876900Phase 3Results posted
• Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for DepressionCompletedNCT01670019Phase 4Results posted
• A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)CompletedNCT01617187Phase 3Results posted
• An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress DisorderCompletedNCT01587118Phase 4Results posted
• Once-Daily Asenapine for SchizophreniaCompletedNCT01549041Phase 4Results posted
• Asenapine in the Treatment of Older Adults With Bipolar DisorderCompletedNCT01460290Phase 4Results posted
• Treating Acutely Agitated Patients With Asenapine Sublingual TabletsCompletedNCT01400113Phase 4Results posted
• Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)CompletedNCT01349907Phase 3Results posted
• Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238)CompletedNCT01244828Phase 3Results posted
• Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)CompletedNCT01244815Phase 3Results posted
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)CompletedNCT01206517Phase 1Results posted
• Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)CompletedNCT01190267Phase 3Results posted
• Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)CompletedNCT01190254Phase 3Results posted
• Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)CompletedNCT01142596Phase 3Results posted
• 6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)CompletedNCT01098110Phase 3Results posted
• Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)CompletedNCT00764478Phase 3Results posted
• Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)CompletedNCT00281320Phase 3Results posted
• 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)CompletedNCT00265343Phase 3Results posted
• 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)CompletedNCT00174265Phase 3Results posted
• 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857)CompletedNCT00159783Phase 3Results posted
• Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)CompletedNCT00156065Phase 3Results posted
• 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)CompletedNCT00145509Phase 3Results posted
• Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)CompletedNCT00145496Phase 3Results posted
• 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)CompletedNCT00145470Phase 3Results posted
• Investigator Initiated Study - Asenapine Early PsychosisStatus unknownNCT01968161Phase 4
• Bio-equivalence Study Between SAPHRIS and AsenapineCompletedNCT01948024Phase 1
• Asenapine for Bipolar DepressionTerminatedNCT01807741Phase 2
• A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental StutteringSuspendedNCT01684657Phase 3
• Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)CompletedNCT01617200Phase 3
• Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)CompletedNCT01396291Phase 3
• Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)CompletedNCT01395992Phase 3
• An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)CompletedNCT00878462Phase 2
• Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)CompletedNCT00212836Phase 3
• Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)CompletedNCT00212784Phase 3
• Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)CompletedNCT00212771Phase 3
• 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)CompletedNCT00159796Phase 3
• 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)CompletedNCT00159744Phase 3
• Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)CompletedNCT00156117Phase 3
• Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)CompletedNCT00156104Phase 3
• Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784)CompletedNCT00156091Phase 3
• Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)CompletedNCT00151424Phase 3
• 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)CompletedNCT00143182Phase 3

← Asenapine overview